Ocumension Therapeutics (HKSE:01477) Operating Cash Flow per Share : HK$-0.30 (TTM As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Operating Cash Flow per Share?

Ocumension Therapeutics's operating cash flow per share for the six months ended in Dec. 2023 was HK$-0.10. Ocumension Therapeutics's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-0.30.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 28.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Ocumension Therapeutics's Operating Cash Flow per Share or its related term are showing as below:

HKSE:01477' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -66.5 Med: -19.2 Max: 28.9
Current: 28.9

During the past 6 years, Ocumension Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.90% per year. The lowest was -66.50% per year. And the median was -19.20% per year.

HKSE:01477's 3-Year OCF Growth Rate is ranked better than
78.08% of 1241 companies
in the Biotechnology industry
Industry Median: 3.7 vs HKSE:01477: 28.90

Ocumension Therapeutics Operating Cash Flow per Share Historical Data

The historical data trend for Ocumension Therapeutics's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Operating Cash Flow per Share Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.21

-0.83

-0.40

-0.35

-0.30

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial						-0.16	-0.09	-0.26	-0.20	-0.10

Competitive Comparison of Ocumension Therapeutics's Operating Cash Flow per Share

For the Biotechnology subindustry, Ocumension Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's Price-to-Operating-Cash-Flow falls into.

Ocumension Therapeutics Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Ocumension Therapeutics's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-194.613	/	649.185
	=	-0.30

Ocumension Therapeutics's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-65.964	/	652.101
	=	-0.10

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.30

Ocumension Therapeutics Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines